Morgan Stanley Maintains Blueprint Medicines (BPMC) Equal-Weight Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on May 5, 2023, Morgan Stanley maintained coverage of Blueprint Medicines (NASDAQ:BPMC) with a Equal-Weight recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1917868586-d64880817bca4098bc8be36bbd17a4e9.jpg "Should You Trade Options on Spot Bitcoin ETFs?")